Novacyt announces 2014 Half Year Results and updates strong progress with integration of Lab21

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its half year results for the six months ended 30th June 2014 approved by the Board of Directors on 28th October 2014. Novacyt also provides an update on the progress of the recent integration of Lab21.

Download press release